Details for New Drug Application (NDA): 206928
✉ Email this page to a colleague
NDA 206928 describes GLIPIZIDE, which is a drug marketed by Aurobindo Pharma, Endo Operations, Norvium Bioscience, Unique, Watson Labs, Zydus Pharms, Accord Hlthcare, Ani Pharms, Apotex, Aurobindo Pharma Usa, Barr Labs Inc, Chartwell Rx, Oxford Pharms, Rubicon, Sandoz, Sun Pharm Inds Inc, Watson Labs Teva, Dash Pharms, Epic Pharma Llc, Heritage, Teva Pharms, and Zydus Pharms Usa Inc, and is included in twenty-six NDAs. It is available from forty-one suppliers. Additional details are available on the GLIPIZIDE profile page.
The generic ingredient in GLIPIZIDE is glipizide; metformin hydrochloride. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the glipizide; metformin hydrochloride profile page.
The generic ingredient in GLIPIZIDE is glipizide; metformin hydrochloride. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the glipizide; metformin hydrochloride profile page.
Summary for 206928
| Tradename: | GLIPIZIDE |
| Applicant: | Aurobindo Pharma |
| Ingredient: | glipizide |
| Patents: | 0 |
Suppliers and Packaging for NDA: 206928
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| GLIPIZIDE | glipizide | TABLET, EXTENDED RELEASE;ORAL | 206928 | ANDA | A-S Medication Solutions | 50090-4297 | 50090-4297-0 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4297-0) |
| GLIPIZIDE | glipizide | TABLET, EXTENDED RELEASE;ORAL | 206928 | ANDA | A-S Medication Solutions | 50090-4297 | 50090-4297-2 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-4297-2) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 2.5MG | ||||
| Approval Date: | May 12, 2017 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 5MG | ||||
| Approval Date: | May 12, 2017 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MG | ||||
| Approval Date: | May 12, 2017 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
